Status:
COMPLETED
Midfacial Gingival Margin Changes Following Immediate Implants.
Lead Sponsor:
Cairo University
Conditions:
Customized Healing Abutment Bone Grafts Connective Tissue Graft Immediate Implant Placement
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Dimensional changes, including the loss of labial soft tissues and midfacial gingival recession, seem to be inevitable following immediate placement. The clinical relevance of this study is proposing ...
Detailed Description
Tooth extraction is followed by ridge alteration and soft tissue collapse and recession. Different strategies were proposed to limit this collapse however, the ability of these techniques to mimic the...
Eligibility Criteria
Inclusion
- Patient-related criteria:
- Adults at or above the age of 18.
- Non-restorable maxillary anterior or premolar tooth requiring extraction and needed an implant placing therapy.
- The failing tooth will have adjacent and opposing natural teeth.
- Sufficient mesial-distal and interocclusal space for placement of the implant and definitive restoration.
- Able to tolerate surgical periodontal procedures.
- Good oral hygiene.
- Compliance with the maintenance program.
- Provide informed consent.
- Accepts the one-year follow-up period.
- Teeth related criteria:
- Intact thick biotype gingival tissue with at least 2mm band of keratinized tissue.
- Intact socket wall before the extraction, buccal bone thickness ≤1mm assessed by CBCT.
- Sufficient apical bone to place an immediate implant with minimum primary stability of 30Ncm
Exclusion
- Patients diagnosed with periodontal diseases.
- Current or previous smokers.
- Pregnant and lactating females.
- Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking IV Bis-phosphonates for treatment of osteoporosis.
- Patients with active infection related at the site of implant/bone graft placement.
- Patients with parafunctional habits
Key Trial Info
Start Date :
January 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT05975515
Start Date
January 13 2022
End Date
May 30 2023
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IDCE
Cairo, Egypt